Celsius Holdings enters the back half of 2026 with a genuinely uncomfortable split: short interest has climbed sharply over the past month while the stock has recovered, and the Street has spent recent weeks cutting price targets even as it holds onto Buy ratings.
The short position tells the most striking story right now. At 15% of the free float, CELH carries a meaningful bear overhang — and that position has grown roughly 34% over the past month, from around 29 million shares to nearly 39 million. That is a substantial build, concentrated in a period when the stock was also recovering. Despite the elevated short level, the borrow market is not particularly strained. Availability runs at 112%, meaning there are still roughly as many shares available to lend as are already borrowed — well within the normal range. Cost to borrow is just 0.55%, a level that imposes no meaningful pressure on shorts. The ORTEX short score of 69.6 sits in elevated territory but has actually eased a fraction from its late-June peak near 70.7, suggesting the pace of positioning is stabilising. Borrow conditions here are not a squeeze setup — shorts are building into a relaxed lending market.
Options traders are not adding much urgency to the picture. The put/call ratio of 0.42 is almost exactly in line with its 20-day average, with a z-score near zero. Call demand continues to dominate the order book. The 52-week range on the PCR — from 0.38 to 0.70 — shows that options positioning has been structurally bullish for most of the past year, and the current reading sits near the low end of that range. There is no hedging build-up ahead of the August 7 earnings date, at least not yet.
The analyst community is telling a more cautious story despite maintaining positive ratings. Over the past two weeks, UBS trimmed its target from $55 to $50 while keeping a Buy, and BofA cut from $55 to $45 — a 18% reduction — while also holding its Buy. Morgan Stanley lowered its target to $48 from $55 in late June, still Overweight. Roth Capital pulled back to $57 from $65. The pattern is consistent: firms are reducing what they are willing to pay for the growth story, even though none are walking away from it. The consensus mean target of $58 implies roughly 83% upside from the current $31.70 — a gap that reflects either a deeply undervalued stock or a Street that has not fully reset expectations to where the stock is trading. Bernstein initiated in June at $44 with an Outperform, adding a fresh voice to the bullish camp but at a target that sits well below older estimates. Factor scores offer some support to the bull case: the forward EPS growth rank is in the 92nd percentile, and analyst recommendation divergence scores at the 95th percentile — meaning CELH attracts stronger analyst conviction than almost all peers. The short score rank, however, sits in just the 4th percentile, flagging the elevated bear position as one of the most concentrated in the universe.
The insider activity from late May adds a counter-note worth registering. CEO John Fieldly bought 8,475 shares at $29.36 on May 22, the President/COO added 7,500 shares the day before at $29.04, and the Lead Independent Director purchased 8,400 shares at $29.73 the same day. Three senior insiders buying within a 48-hour window near the stock's recent lows reads as a deliberate signal of confidence. Net insider activity over the 90 days to May 29 was modestly positive at just over $1.3 million. The stock has since recovered to $31.70 — up roughly 8% on the week, though it gave back 4% on Tuesday alone.
Earnings reaction history gives pause. The last four prints produced an average next-day move of roughly -2%, but the five-day drift was consistently negative — ranging from -11% to -12%. Whatever the initial reaction, the stock has tended to fade meaningfully into the week following results. With Q2 numbers due August 7 and short interest at a multi-month high, the degree to which the earnings print either validates or challenges the bull case on international expansion and PepsiCo partnership execution is the number to watch.
See the live data behind this article on ORTEX.
Open CELH on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
